Advanced search
Publication Cover
OncoTargets and Therapy Volume 6, 2013 - Issue
Submit an article Journal homepage
83
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Comparative study analyzing survival and safety of bevacizumab/carboplatin/paclitaxel and cisplatin/pemetrexed in chemotherapy-naïve patients with advanced non-squamous bronchogenic carcinoma not harboring EGFR mutation

Yasser Abdel Kader1 Department of Clinical Oncology, Cairo University, Cairo, Egypt
,
Thierry Le Chevalier2 Department of Medical Oncology, Institut Gustave Roussy, Villejuif, Paris, France
,
Tamer El-Nahas1 Department of Clinical Oncology, Cairo University, Cairo, EgyptCorrespondence[email protected]
&
Amr Sakr1 Department of Clinical Oncology, Cairo University, Cairo, Egypt
Pages 803-809 | Published online: 01 Jul 2013

References

  • Karim-KosHEde VriesESoerjomataramILemmensVSieslingSCoeberghJWRecent trends of cancer in Europe: a combined approach of incidence, survival, and mortality for 17 cancer sites since the 1990sEur J Cancer200844101345138918280139
  • GovindanRPageNMorgenszternDChanging epidemiology of small-cell lung cancer in the United States over the last 30 years: analysis of the surveillance, epidemiologic, and end results databaseJ Clin Oncol200624284539454417008692
  • PfisterDGJohnsonDHAzzoliCGAmerican Society of Clinical Oncology treatment of unresectable non-small-cell lung cancer guideline: update 2003J Clin Oncol200422233035314691125
  • SchillerJHHarringtonDBelaniCPComparison of four chemotherapy regimens for advanced non-small-cell lung cancerN Engl J Med20023462929811784875
  • ScagliottiGVDe MarinisFRinaldiMPhase III randomized trial comparing three platinum-based doublets in advanced non-small-cell lung cancerJ Clin Oncol200220214285429112409326
  • KellyKCrowleyJBunnPAJrRandomized phase III trial of paclitaxel plus carboplatin versus vinorelbine plus cisplatin in the treatment of patients with advanced non-small-cell lung cancer: a Southwest Oncology Group trialJ Clin Oncol200119133210321811432888
  • FossellaFPereiraJRvon PawelJRandomized, multinational, phase III study of docetaxel plus platinum combinations versus vinorelbine plus cisplatin for advanced non-small-cell lung cancer: the TAX 326 study groupJ Clin Oncol200321163016302412837811
  • Le ChevalierTScagliottiGNataleREfficacy of gemcitabine plus platinum chemotherapy compared with other platinum containing regimens in advanced non-small-cell lung cancer: a meta-analysis of survival outcomesLung Cancer2005471698015603856
  • TaylorECKuhntDShihCA dideazatetrahydrofolate analogue lacking a chiral center at C-6, N-[4-[2-(2-amino-3,4-dihydro-4-oxo-7H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]-L-glutamic acid, is an inhibitor of thymidylate synthaseJ Med Chem19923523445044541447744
  • SchultzRMPatelVFWorzallaJFShihCRole of thymidylate synthase in the antitumor activity of the multitargeted antifolate, LY231514Anticancer Res1999191A43744310226579
  • ShihCHabeckLLMendelsohnLGChenVJSchultzRMMultiple folate enzyme inhibition: mechanism of a novel pyrrolopyrimidine-based antifolate LY231514 (MTA)Adv Enzyme Regul1998381351529762351
  • VogelzangNJRusthovenJJSymanowskiJPhase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesotheliomaJ Clin Oncol200321142636264412860938
  • ScagliottiGVParikhPvon PawelJPhase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancerJ Clin Oncol200826213543355118506025
  • SigmondJBackusHHWoutersDTemminkOHJansenGPetersGJInduction of resistance to the multitargeted antifolate Pemetrexed (ALIMTA) in WiDr human colon cancer cells is associated with thymidylate synthase overexpressionBiochem Pharmacol200366343143812907242
  • GiovannettiEMeyVNannizziSCellular and pharmacogenetics foundation of synergistic interaction of pemetrexed and gemcitabine in human non-small-cell lung cancer cellsMol Pharmacol200568111011815795320
  • CeppiPVolanteMSaviozziSSquamous cell carcinoma of the lung compared with other histotypes shows higher messenger RNA and protein levels for thymidylate synthaseCancer200610771589159616955506
  • SandlerAGrayRPerryMCPaclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancerN Engl J Med2006355242542255017167137
  • Avastin® (bevacizumab) [package insert]South San Francisco, CA, USAGenentech Inc2007
  • JohnsonDHFehrenbacherLNovotnyWFRandomized phase II trial comparing bevacizumab plus carboplatin and paclitaxel with carboplatin and paclitaxel alone in previously untreated locally advanced or metastatic non-small-cell lung cancerJ Clin Oncol200422112184219115169807
  • SandlerABevacizumab in non-small cell lung cancerClin Cancer Res20071315 Pt 2s4613s461617671151
  • TherassePArbuckSGEisenhauerEANew guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of CanadaJ Natl Cancer Inst200092320521610655437
  • OkenMMCreechRHTormeyDCToxicology and response criteria of the Eastern Cooperative Oncology GroupAm J Clin Oncol1982566496557165009
  • CockcroftDWGaultMHPrediction of creatinine clearance from serum creatinineNephron197616131411244564
  • ReckMvon PawelJZatloukalPPhase III trial of cisplatin plus gemcitabine with either placebo or bevacizumab as first-line therapy for nonsquamous non-small-cell lung cancer: AVAiLJ Clin Oncol2009271227123419188680

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.